Blogs Archives - OHC - Oncology Hematology Care

Blogs

OHC Doctor Is Leading an Evaluation of a Potential New Treatment for Acute Myeloid Leukemia, the Most Common Blood Cancer in Adults
OHC, Specialists in Cancer and Blood Disorders, Blogs 0 comments
November 12, 2019

Following their ongoing commitment to provide patients with the latest treatment options, doctors at OHC are evaluating another new treatment option for patients diagnosed with acute myeloid leukemia (AML). This treatment is for AML patients who are ineligible to receive standard chemotherapy due to existing medical conditions. “Patients with AML, especially older patients, often have […]
Read More
OHC Doctor Is Leading a National Clinical Trial to Help Patients with Lung Cancer.
OHC, Specialists in Cancer and Blood Disorders, Blogs 0 comments
November 6, 2019

OHC’s David M. Waterhouse, MD, MPH, is leading a national clinical trial as the principal investigator to evaluate a new treatment option for patients whose advanced non-small cell lung cancer has not responded to chemotherapy or immunotherapy treatments. “Cancer is a very individualized disease in that one person’s cancer isn’t the same as another person’s […]
Read More
OHC is Helping Patients with Pancreatic Cancer Beat The Odds
OHC, Specialists in Cancer and Blood Disorders, Blogs 0 comments
November 5, 2019

At OHC, our cancer doctors want to be able to tell every patient their cancer is in remission, and for patients with pancreatic cancer, that is a special gift. While pancreatic cancer survival rates have been improving over the last several decades, the disease is still considered largely incurable. According to the American Cancer Society, the one-year survival rate is […]
Read More
OHC Is Assessing All New Breast Cancer Patients Against National Guidelines to Determine if They Should Seek Genetic Testing
OHC, Specialists in Cancer and Blood Disorders, Blogs 0 comments
November 4, 2019

OHC is leading the way in the fight against breast cancer by assessing every new OHC breast cancer patient against national guidelines that will determine if they should seek genetic testing for mutations. It’s important for patients to know this information because it can help them and the care team make decisions such as surgical […]
Read More
OHC is Evaluating the Expanded Use of the Ground-breaking CAR T-cell Therapy
OHC, Specialists in Cancer and Blood Disorders, Blogs 0 comments
October 22, 2019

OHC, the region’s leading cancer experts, has opened two new clinical trials to evaluate an expanded use of the ground-breaking treatment, chimeric antigen receptor T-cell therapy (CAR-T), making this life-changing treatment available to more patients. Not all patients diagnosed with a blood cancer experience a response from traditional treatments. Others aren’t eligible for treatments due […]
Read More
Ladies Night Out: Sips, Dips and Tips on Taking Control of Your Health
OHC, Blogs, Events 0 comments
October 21, 2019
Join Us for Ladies Night Out: Sips, Dips and Tips on Taking Control of Your Health, Featuring OHC’s Mark E. Johns, MD, medical oncologist and hematologist Wednesday, October 23 5:00 – 7:30pm Mercy Health – Eastgate Medical Center 601 Ivy Gateway, Cincinnati 45245 (across from Total Quality Logistics) Register: Ladies Night Out is free, but space is limited. Register here or […]
Read More
OHC is Evaluating a Promising New Treatment for Women with Triple Negative Breast Cancer
OHC, Specialists in Cancer and Blood Disorders, Blogs 0 comments
October 10, 2019

OHC is evaluating a new treatment option for triple negative breast cancer through its clinical trials program. The results of the trial may provide new hope for women diagnosed with this aggressive form of breast cancer. Triple-negative breast cancer (TNBC) is a cancer that tests negative for estrogen receptors, progesterone receptors, and excess HER2 protein. […]
Read More